Original article
Risk for gonococcal and chlamydial cervicitis in adolescent females: Incidence and recurrence in a prospective cohort study

https://doi.org/10.1016/1054-139X(95)00232-HGet rights and content

Purpose:

This study attempted to determine the incidence and risk for gonococcal and chlamydial cervicitis among sexually active urban adolescent females.

Methods:

The study design is a prospective cohort study. A cohort of 216 sexually active females were followed with repeat sexually transmitted diseases screening for 12-24 months. Subjects positive on any retest (FU) were compared with those who remained negative on all FU. Subjects were interviewed for history and screened for endocervical gonococcal and chlamydial infection.

Results:

The number of visits per patient ranged from 2 to 9 (median, 3). The initial Chlamydia trachomatis and Neisseria gonorrhoeae rates were 23.2 and 11.6%, respectively. The cumulative FU positive rates were 20.8% for C. trachomatis and 17.1% for N. gonorrhoeae. Although the initial gonococcal infection was a significant risk for a subsequent infection by C. trachomatis (p = .05) and N. gonorrhoeae (p = .001), the initial C. trachomatis status was not predictive of subsequent infections. The number of partners was not predictive of subsequent infections with either. In the entire study period, 86 patients had at least one episode of C. trachomatis and N. gonorrhoeae infection was confirmed in 52; 20 patients had recurrent cervicitis. During the study, 101 episodes of C. trachomatis and 68 episodes of N. gonorrhoeae infections were identified. Those with recurrent cervicitis (9.3%) were responsible for 33% of all cervicitis episodes identified during the study.

Conclusions:

Adolescents in our study were at high risk for cervicitis, particularly as a result of C. trachomatis. Risk for subsequent C. trachomatis cervicitis was the same among initially positive and negative groups. Our data underscore the importance of repeat screening for sexually transmitted infections and treatment of contacts of adolescent females.

References (23)

  • McEvoyFM et al.

    A 13-year longitudinal analysis of risk factors and clinic visitation patterns of patients with repeated gonorrhea

    Sex Transm Dis

    (1988)
  • Cited by (60)

    • Gonococcal Infection in Women

      2013, Women and Health
    • Gonococcal Infection in Women

      2012, Women and Health, Second Edition
    • Innovative approaches to the prevention and control of bacterial sexually transmitted infections

      2005, Infectious Disease Clinics of North America
      Citation Excerpt :

      Prospective studies with active follow-up have observed chlamydial infection in 7% to 25% of women and 13% of men tested 3 to 6 months after treatment for genital C trachomatis infection [88–92], and rescreening of young women who have chlamydial infection has been shown to be cost-effective [93]. Although fewer data are available on gonorrhea, recurrent infections have been reported in 12% to 24% of women and 9% of men tested 1 to 6 months after treatment [92,94,95]. The argument in favor of rescreening is strong, but is not new [96].

    • Are adolescent girls with chlamydia infection notifying their partners?

      2005, Journal of Pediatric and Adolescent Gynecology
      Citation Excerpt :

      Sexually active adolescent girls are at high risk for genital chlamydia infection and for recurrent infections.4–6 Prevalence estimates of asymptomatic chlamydia infection in adolescent girls ranges from 7% to 29% and 16% to 18% of adolescent girls have a repeat infection, with a median time interval of approximately 6 months.6–9 Partner notification and treatment is key to prevention of recurrent infection.

    • Urethritis and cervicitis in adolescents

      2004, Adolescent Medicine Clinics
    View all citing articles on Scopus

    This study was supported by Grant R30/CCR405030 from the Centers for Disease Control and Prevention, Atlanta, Georgia. This research was presented in part at the annual meeting of the International Association of Adolescent Health, March 20–22, 1995, Vancouver, Canada.

    View full text